IL6 and early-onset autosomal dominant Alzheimer disease: Broadly speaking, IL-6 trans-signaling propagates inflammation in the central nervous system (CNS), facilitating microgliosis and astrocytosis through chemokine signaling, contributing to sickness behaviors and cognitive deficits in mice, and increasing risk for neurodegenerative disorders like Alzheimer’s disease [7, 15–19].